Skip to main content
Premium Trial:

Request an Annual Quote

Pronota Signs Up for Thermo Fisher Peptide Service

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific yesterday said that Belgian molecular diagnostics firm Pronota is using the firm’s new HeavyPeptide FasTrack service, which provides a selection of crude heavy peptides for more rapid development of protein assays.
Thermo Fisher said that the crude peptides are used in mass spectrometry setup to identify the best proteotypic peptides. After customers identify their candidates, Thermo Fisher uses retained crude stock to rapidly produce the final purified heavy peptides as HeavyPeptide Aqua Kits.
Pronota uses its own MASStermind mass spec platform for biomarker validation and is developing tests based on the protein biomarkers. The firm also provides pharmaceutical partners with biomarker discovery and validation services.
“In the past, we had to wait four to five weeks for purified peptides,” said Katleen Verleysen, vice president of operations and technology development at Pronota. “Now, we get the crude peptides in about 10 days and can start building our assays right away.”
Terms of the alliance were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more